Muscarinic receptor agonist that displays roughly equal affinity at all receptor subtypes (Ki
values are 2.3, 2.4, 3.6, 3.8 and 4.3 μ
M for hM1
receptors respectively). Cognitive enhancer; reverses spatial memory deficits in rats.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preclinical and phase I clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease.
Sedman et al.
Life Sci., 1995;56:877
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
Wood et al.
Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization.
Schwarz et al.